Results 1 to 2 of 2

Thread: EULAR 2011 - Vidofludimus Superior To Cyclophosphamide And MMF In An Experimental Sys

Threaded View

  1. #1
    Join Date
    Nov 2009
    Posts
    146
    Thanks
    0
    Thanked 20 Times in 13 Posts

    Default EULAR 2011 - Vidofludimus Superior To Cyclophosphamide And MMF In An Experimental Sys

    4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune and cancer diseases, will present pre-clinical data on vidofludimus - its lead small-molecule drug candidate against autoimmune diseases - in systemic lupus erythematosus (SLE) at EULAR 2011, Europe's largest scientific conference on rheumatic diseases, i...

    More...

  2. The Following User Says Thank You to RSS Bot For This Useful Post:

    ferrini (05-27-2011)

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •